Compared with the DSS induced colitis mice model group (Figure 2A–2D), administration of Schisandrin B more significantly reduced the serum TNF-α, IL-6, IL-18 and IL-1β levels in DSS induced colitis mice model. This evidence concerns the gene IL18 and colitis.